Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'zd 7155 hydrochloride'

Search results for: 'zd 7155 hydrochloride'

Items 1-10 of 630

Page
per page
  1. ZD 7114 hydrochloride
    B6509 ZD 7114 hydrochloride
    Summary: β3-adrenoceptor agonist
      <45.49 mg/mL
  2. SAR407899 hydrochloride
    B4909 SAR407899 hydrochloride
    Summary: ATP-competitive ROCK inhibitor
      Soluble in DMSO
  3. Vandetanib hydrochloride
    A3906 Vandetanib hydrochloride
    Summary: VEGFR/EGFR inhibitor
      ≥51.2 mg/mL
  4. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  5. ZD 7288
    B6542 ZD 7288
    Summary: HCN channel inhibitor
      Soluble in DMSO
  6. ZD 2079
    B5263 ZD 2079
    Summary: β3-adrenoceptor agonist
      <8.8 mg/mL
  7. ZD 9379
    B5409 ZD 9379
    Summary: NMDA receptor antagonist
      <19.19 mg/mL
  8. Istaroxime hydrochloride
    A3508 Istaroxime hydrochloride
    Summary: Inhibitor of Na+/K+ ATPase
      Soluble in DMSO
  9. KN-92 hydrochloride
    A3530 KN-92 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: Inactive derivative of KN-93,control compound
      ≥24.65 mg/mL
  10. YM-155 hydrochloride
    A3947 YM-155 hydrochloride
    Summary: Potent survivin inhibitor
      ≥19.45 mg/mL

Items 1-10 of 630

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 530item
  2. Natural Products 14item
  3. Amino Acids & Building Blocks 1 item
  4. Screening Library 33item
  5. Probes & Dyes 2item
  6. Protein & Immunology 2item
  7. Lab Reagents 15item
Specificity
  1. Selective 40item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. GSK-3 1 item
  11. VEGFR 1 item
  12. PDGFR 1 item
  13. c-Kit 1 item
  14. Phosphodiesterases (PDEs) 2item
  15. Thymidylate Synthase 1 item
  16. p38 1 item
  17. GABAB Receptors 1 item
  18. Sir2-like Family Deacetylases (Sirtuins) 1 item
  19. Aminopeptidases 1 item
  20. EGFR 3item
  21. FAK 1 item
  22. Syk 1 item
  23. DNA-PK 1 item
  24. HSP90 1 item
  25. AMPK 1 item
  26. Gutathione S-transferase 1 item
  27. Topoisomerases 1 item
  28. Serine Proteases 1 item
  29. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  30. Pyk2 1 item
  31. 5-HT2 Receptors 2item
  32. S1P receptors 1 item
  33. ALK 1 item
  34. Myosin light chain kinases (MLCKs) 1 item
  35. 5-HT3 Receptors 2item
  36. Angiotensin-Converting Enzymes (ACEs) 1 item
  37. Squalene epoxidases 3item
  38. Nampt 1 item
  39. Glutamate (Metabotropic) Group I Receptors 1 item
  40. Urokinases 1 item
  41. Histamine H1 Receptors 1 item
  42. Sigma Receptors 1 item
  43. Apoptosis Inducers 1 item
  44. AChE 1 item
  45. Inward Rectifier Potassium (Kir) Channels 1 item
  46. c-RET 1 item
  47. guanylyl cyclase 1 item
  48. dopamine receptor 1 item
  49. 5-HT1 Receptor 2item
  50. 5-HT2 Receptor 1 item
  51. NMPRTase 1 item
  52. IKK 1 item
  53. Antibiotic 1 item
  54. Calmodulins 1 item
  55. Calcium-Sensing Receptors (CaSRs) 2item
  56. PAR receptor 1 item
  57. TRPC channel 1 item
  58. GABAA receptor 1 item
  59. CRF1 Receptors 1 item
Reported Experiments
  1. Animal Experiments 63item
  2. Cell Experiments 60item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 3item
  4. Breast Cancer 4item
  5. Cancer 21item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 3item
  8. Colorectal Cancer 4item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 3item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Liver Cancer 1 item
  16. Lung Cancer 3item
  17. Multidrug Resistance Studies 1 item
  18. Multiple Myeloma 2item
  19. Narcolepsy 1 item
  20. Non-small Cell Lung Cancer 1 item
  21. Ovarian Cancer 1 item
  22. Pancreatic Cancer 3item
  23. Prostate Cancer 4item
  24. Schizophrenia 1 item
  25. Type 2 Diabetes 1 item